Alembic announces USFDA final approval for Pantoprazole Sodium for Injection, 40 mg/vial
Pantoprazole Sodium for Injection, 40 mg/vial (Single-Dose Vial) have an estimated market size of US$ 48 million for twelve months ending December 2024 according to IQVIA